Recent Publications (as of 1/6/25)
Donahoe JT, Brown-Podgorski BL, Gaire S, Krans EE, Jarlenski M. Advanced Child Tax Credit Monthly Payments and Substance Use Among US Parents. JAMA Health Forum. 2025 Jan 3;6(1):e244699. doi: 10.1001/jamahealthforum.2024.4699. PMID: 39752172; PMCID: PMC11699525.
Chappell CA, Kiser JJ, Brooks KM, Randolph R, Macio IS, Meyn LA, MaWhinney S, Rick AM, Muniz GB, Kwon KM, Letterio C, Naik S, Kreter B, Bunge KE, Krans EE, Hillier SL. Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People with Hepatitis C Virus. Clin Infect Dis. 2024 Dec 17:ciae595. doi: 10.1093/cid/ciae595. Epub ahead of print. PMID: 39688397.
Alshogran OY, Zhao W, Krans EE, Caritis S, Shaik IH, Venkataramanan R. An Approach for Improving the Detection and Quantitation of Buprenorphine and Its Metabolites in Maternal and Neonatal Hair. Ther Drug Monit. 2024 Dec 13. doi: 10.1097/FTD.0000000000001291. Epub ahead of print. PMID: 39671206.
Jarlenski M, LoCiganic WH, Chen Q, Pudasainy S, Donohue JM, Cole ES, Krans EE. Association between buprenorphine dose and outcomes among pregnant persons with opioid use disorder. Am J Obstet Gynecol. 2024 Dec 6:S0002-9378(24)01178-5. doi: 10.1016/j.ajog.2024.12.001. Epub ahead of print. PMID: 39647655.
Hull I, Jawa R, Shang M, Davis C, King C, McMurtrie G, Krans EE. Implications of xylazine exposure in pregnancy: a narrative review. J Addict Dis. 2024 Aug 21:1-8. doi: 10.1080/10550887.2024.2391156. Epub ahead of print. PMID: 39166266.
Guyon-Harris KL, Krans EE, Gill A, Karnosh C, Shaw DS. Supporting positive parenting among pregnant people in recovery from opioid use disorder: Introducing family check‐up–prenatal. Infant Ment Health J. 2024 Aug 8. English. doi: 10.1002/imhj.22132. Epub ahead of print. PMID: 39118311.
Winhusen TJ, Kropp F, Greenfield SF, Krans EE, Lewis D, Martin PR, Gordon AJ, Davies TH, Wachman EM, Douaihy A, Parker K, Xin X, Jalali A, Lofwall MR. Trauma Prevalence and Its Association With Health-Related Quality of Life in Pregnant Persons with Opioid Use Disorder. J Addict Med. 2024 Aug 6. doi: 10.1097/ADM.0000000000001366. Epub ahead of print. PMID: 39105509.
Frankeberger J, Coulter RWS, Jarlenski M, Krans EE, Mair C. Co-occurring conditions during pregnancy and hospitalizations in the first year postpartum among persons with opioid use disorder. Prev Med. 2024 Aug;185:108057. doi: 10.1016/j.ypmed.2024.108057. Epub 2024 Jun 26. PMID: 38942123; PMCID: PMC11421478.
Zhao W, Alshogran OY, Zhang H, Joshi A, Krans EE, Caritis S, Shaik IH, Venkataramanan R. Simplified processing and rapid quantification of buprenorphine, norbuprenorphine, and their conjugated metabolites in human plasma using UPLC-MS/MS: Assessment of buprenorphine exposure during opioid use disorder treatment. J Mass Spectrom. 2024 Apr;59(4):e5015. doi: 10.1002/jms.5015. PMID: 38501738.
Lim G, Xue L, Donohue JM, Junker S, Wilson JD, Suffoletto B, Lynch MJ, Pacella-LaBarbara ML, Chang CH, Krans EE, Jarlenski M. Associations between acute pain after vaginal delivery and postpartum opioid prescription fills: a retrospective case-controlled study. Br J Anaesth. 2024 May;132(5):978-981. doi: 10.1016/j.bja.2024.01.038. Epub 2024 Feb 29. PMID: 38423825.